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Cerebral white matter hyperintensities (WMHs) have been associated with vascular risk factors, both of
which are under genetic inﬂuence. We examined in a monozygotic twin sample whether the association
between vascular risk and WMHs is inﬂuenced by overlapping genetic factors. We included 195 cogni-
tively normal monozygotic twins (age ¼ 70  7 years), including 94 complete pairs. Regional WMH load
was estimated using an automated algorithm. Vascular risk was summarized with the Framingham score.
The withinetwin pair correlation for total WMHs was 0.76 and for Framingham score was 0.77. Within
participants, Framingham score was associated with total and periventricular WMHs (r ¼ 0.32). Fra-
mingham score in 1 twin was also associated with total WMHs in the co-twin (r ¼ 0.26). Up to 83% of the
relation between both traits could be explained by shared genetic effects. In conclusion, monozygotic
twins have highly similar vascular risk and WMH burden, conﬁrming a genetic background for these
traits. The association between both traits is largely driven by overlapping genetic factors.
 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cerebral white matter hyperintensities (WMHs) on ﬂuid-
attenuated inversion recovery (FLAIR) magnetic resonance imag-
ing (MRI) scans are a common ﬁnding in older adults (Launer, 2004)
and are associated with risk of cognitive decline (De Groot et al.,
2002; Debette and Markus, 2010; Prins et al., 2004). They are
found in the periventricular and deep white matter. Although the
etiology of WMHs is not yet fully understood, they are often
considered to be a manifestation of small vessel disease. WMHs
have been associated with the presence of various vascular risk
factors, such as hypertension, diabetes, and smoking (Dickie et al.,
2016; Habes et al., 2016; Wardlaw et al., 2015).
The occurrence of WMHs is under genetic inﬂuence. Previous
family and twin studies have found heritability estimates ofepartment of Neurology, VU
msterdam, the Netherlands.
9.
).
Inc. This is an open access article u0.55e0.81 for total WMH load (Atwood et al., 2004; Carmelli et al.,
1998; Fennema-Notestine et al., 2016; Sachdev et al., 2016; Turner
et al., 2004). Heritability studies have also found a moderate-to-
strong genetic inﬂuence on the presence of various vascular risk
factors such as blood pressure and hypertension (Evans et al., 2003;
Kupper et al., 2005), impaired glucose tolerance (Poulsen et al.,
1999), serum cholesterol and high-density lipoprotein (HDL)
levels (Elder et al., 2009; Goode et al., 2007; Rahman et al., 2009),
and smoking (Vink et al., 2005). It is not yet clear whether vascular
risk factors are independently associated with increased WMHs or
whether there are common underlying genetic factors that inﬂu-
ence both vascular risk factors and the presence of WMHs.
Monozygotic twins are genetically identical and partly share
environmental factors. Similarity of a trait withinmonozygotic twin
pairs can be due to either genetic factors or shared environmental
factors, whereas differences result from nonshared environmental
factors. To disentangle the contribution of genetic and shared
environmental factors to a trait, classic twin design studies also
include dizygotic twins, who share 50% of their segregating genes
and are assumed to have a similar amount of shared environmentalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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monozygotic twin pairs. Previous studies including monozygotic
and dizygotic twins have shown that the presence of WMHs is best
explained by a model including genetic effects and nonshared
environmental factors, eliminating shared environmental in-
ﬂuences from the model (Carmelli et al., 1998; Fennema-Notestine
et al., 2016; Sachdev et al., 2016). Similarly, twin studies have found
that shared environmental inﬂuences do not predict vascular risk
factors such as blood pressure and hypertension (Evans et al., 2003;
Kupper et al., 2005; Panizzon et al., 2015), impaired glucose toler-
ance (Poulsen et al., 1999), and serum cholesterol and HDL levels
(Elder et al., 2009; Rahman et al., 2009), although not in all studies
(Jermendy et al., 2011). Together, this suggests that similarity in
WMHs and vascular risk factors within monozygotic twin pairs is
most likely attributable to genetic factors.
In this study, we have ﬁrst examined the correlation of vascular
risk factors and WMH volume, location, and pattern within cogni-
tively normal older adult monozygotic twin pairs. We then assessed
whether overlapping genetic factors could underlie the association
between vascular risk factors and WMHs by examining the simi-
larity within monozygotic twin pairs for these traits. As a summary
measure for vascular risk factors, we used the Framingham score
(D’Agostino et al., 2008; Habes et al., 2016), but we also tested
correlation for each vascular risk factor included in this score with
WMHs. As differences in heritability estimates of WMHs have been
found between males and females, we also examined gender dif-
ferences in these traits (Atwood et al., 2004; Sachdev et al., 2016).
2. Materials and methods
2.1. Participants
Monozygotic twins were included from the Amsterdam sub-
study of the European Medical Information Framework for Alz-
heimer’s Disease PreclinAD cohort, a longitudinal study on risk
factors for amyloid pathology and cognitive decline in cognitively
normal older adults. Inclusion criteria were having age above
60 years, a delayed recall score of >1.5 SD of age-adjusted
normative data on the Consortium to Establish a Registry for Alz-
heimer’s Disease (CERAD) 10-word list (Morris et al., 1989), a global
Clinical Dementia Rating score of 0 (Morris, 1993), Telephone
Interview for Cognitive Status modiﬁed (TICS-m) score of 23 or
higher (de Jager et al., 2003), and a 15-item Geriatric Depression
Scale score of <11 (Yesavage et al., 1982). Exclusion criteria were
any signiﬁcant neurologic, systemic, or psychiatric disorder that
could cause cognitive impairment. Participants were recruited be-
tween December 2014 and August 2016 from the Netherlands Twin
Registry (Boomsma et al., 2006; Willemsen et al., 2013). All par-
ticipants were asked to collect mucosal cell samples for DNA
extraction to conﬁrm zygosity. From the Amsterdam PreclinAD
cohort, we excluded 6 participants due to missing MRI data (1 due
to claustrophobia, 1 due to technical issues with the scanner, and 4
due to participant refusal to visit the hospital), 1 participant due to
the presence of multiple sclerosis-like lesions on MRI, and 1 dizy-
gotic twin pair. For the present study, we used 195 participants, of
which 94 were complete monozygotic twin pairs and 7 single
participants. The study was approved by the VU University Medical
Center’s ethics committee, and all participants gave written
informed consent.
2.2. Clinical and vascular risk assessment
Clinical data were collected during a face-to-face interview for
medical history, medication intake, smoking habits, and educa-
tional attainment. All participants also underwent physicalexaminations. Blood pressure was measured 3 times in a lying
position with a 5-minute interval between measurements, and the
mean of these 3 measurements was used for the analysis. After a
minimum 2-hour fasting period, participants underwent a blood-
draw to determine lipid proﬁle and glycated hemoglobin in the
morning. The cardiovascular risk proﬁle for each participant was
summarized using the Framingham score index, which includes the
following factors: age, gender, total cholesterol, HDL, systolic blood
pressure, antihypertensive medication use, diabetes mellitus, and
smoking (D’Agostino et al., 2008). This risk index represents the 10-
year risk of a major cardiovascular event. All clinical, cognitive, and
MRI measurements were performed within 6 months (median
16 days).
2.3. Image acquisition
Whole-brain scans were obtained using a single 3T scanner
(Philips Ingenuity Time-of-Flight PET/MRI scanner) using an 8-
channel head coil. Isotropic structural 3D T1-weighted images
were acquired using a sagittal turbo ﬁeld echo sequence (1.00 mm3
isotropic voxels, repetition time ¼ 7.9 ms, echo time ¼ 4.5 ms, and
ﬂip angle ¼ 8); 3D sagittal FLAIR sequences (1.12 mm3 isotropic
voxels, repetition time ¼ 4800 ms, echo time ¼ 279 ms, and
inversion time¼ 1650 ms) were acquired for the analysis of WMHs.
The MR protocol also included susceptibility weighted imaging. All
MRI scans were visually assessed by an experienced neuroradiol-
ogist for incidental ﬁndings.
2.4. MRI analysis
All MRI scans were visually rated by a single experienced rater
(MtK) who was blind to twin pairing at the time of rating. WMHs
were visually assessed on the 3D FLAIR images using the 4-point
Fazekas scale for deep WMHs (none, punctuate, early conﬂuent,
and conﬂuent; Fazekas et al., 1987). Lacunes were deﬁned as deep
lesions between 3 and 15 mm with cerebrospinal ﬂuidelike signal
on T1-weighted and FLAIR images. Microbleeds were assessed on
susceptibility weighted images and deﬁned as rounded hypo-
intense homogeneous foci of up to 10 mm in the brain parenchyma.
Medial temporal lobe atrophy was assessed on coronal
reconstructions of the T1-weighted images using the 5-point
Scheltens’ scale (Scheltens et al., 1992). Global cortical atrophy
was rated on transversal FLAIR images using a 4-point scale
(Pasquier et al., 1996).
Quantitative WMH load was estimated jointly from both 3D T1
and 3D FLAIR scans using a previously described algorithm (Sudre
et al., 2015). Details of the WMH lesion segmentation are pro-
vided in the Supplementary Methods. To visually represent the
distribution of WMHs in the brain, a coordinate frame (bullseye)
was designed to characterize the location based on the normalized
distance between the ventricular surface and cortex (4 layers) and
the left/right cortical lobes (frontal, parietal, temporal, and occipi-
tal) or basal ganglia. Overall 36 regions (4 layers, 9 lobar regions)
were deﬁned to characterize the location of WMHs. Fig. 1 illustrates
the deﬁnition of layers and lobar regions and presents an example
of a bullseye representation of this local information. Infratentorial
structures (i.e., brain stem and cerebellum) were not taken into
account because of the lowWMH lesion load in these regions in this
cohort. All WMH segmentations were visually inspected, and none
had to be excluded.
2.5. Statistical analysis
All statistical analyses were performed in R (R, version 3.3.1;
http://www.R-project.org).
Fig. 1. Segmentation of WMHs and regional classiﬁcation in a single participant. Left: WMHs are estimated from T1 and FLAIR images and subsequently regionally classiﬁed
according to anatomical lobes and distance from the ventricular system. This results in 36 regions, which can be visualized with a bullseye plot. Right: The bullseye plot representing
the WMH lesion load in the different regions from periventricular (center) to subcortical (outer ring) and according to anatomical lobe. Abbreviations: BG, basal ganglia and
thalamus; FLAIR, ﬂuid-attenuated inversion recovery; FRONT, frontal; OCC, occipital; PAR, parietal; TEMP, temporal; WMH, white matter hyperintensity.
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twins
Monozygotic twin correlations for vascular risk factors, total
WMH, and regional WMH measures were assessed using Pearson
correlation. Because the Framingham score and WMH frequencies
were left skewed, we used a log-transformation to normalize the
distributions. Correlation analyses for WMHs were adjusted for the
effects of regional white matter volume, age, and gender. Because
monozygotic twins are genetically identical, within-pair correla-
tions reﬂect the upper limit of genetic contribution to a trait. Cor-
relation analyses were repeated for random (nontwin) pairings of
participants.
Next, we examined the similarity of the pattern of WMH mea-
sures across regions for each twin pair. As a measure of similarity,
we computed the Pearson correlation of WMH volumes across all
regions between a participant and his/her co-twin for each pair (i.e.,
instead of computing the correlation within twins for each region,
we correlated regional WMH values of twin 1 with the regional
WMH values of twin 2 for each twin pair). This correlation was also
estimated for all nontwin participant pairs. Because some regions
are prone to have more WMHs than others, WMH volumes were
centered per region before computing the within-pair correlations.
2.5.2. Relation between vascular risk factors and WMHs
Our second aim was to examine the relation between vascular
risk factors and WMHs. We pooled WMH volume of left and right
hemispheres. We used the total WMH load (all layers), periven-
tricular WMH load (layers 1 and 2), and deep WMH load (layers 3
and 4) for total brain and for each lobe separately and normalized
them by the respective regional white matter volumes. The relation
between Framingham score and WMH was ﬁrst assessed using
generalized estimating equations (GEEs), with Framingham score as
a predictor and WMHs as a dependent variable adjusting for twin
status (model 1) and for twin status, age, and gender (model 2)
(Minica et al., 2015).
The next analyses, aimed at further scrutinizing the relation
between vascular risk factors and WMH, were only run for those
regions in which there was a signiﬁcant relation between Fra-
mingham score and WMHs in the GEE analysis.2.5.3. Shared genetic inﬂuences between vascular risk factors and
WMHs
Next, we examined whether the association between WMHs
and Framingham score could be explained by overlapping additive
genetic effects. We used structural equation modeling imple-
mented in OpenMx (Boker et al., 2011) to compute the within-
participant correlation between Framingham score and regional
WMHs and the cross-twin cross-trait correlation (i.e., the correla-
tion of the Framingham score in 1 twin with WMH load in the
cotwin). The correlation between Framingham score and WMHs
can be decomposed into a genetic and an environmental constit-
uent. Previous studies have found no signiﬁcant effect of shared
environmental factors on WMHs (Carmelli et al., 1998; Fennema-
Notestine et al., 2016; Sachdev et al., 2016) and various vascular
risk factors (Elder et al., 2009; Evans et al., 2003; Kupper et al.,
2005; Panizzon et al., 2015; Poulsen et al., 1999; Rahman et al.,
2009). In our sample of monozygotic twins, we therefore
assumed a model in which we only consider additive genetic (A)
and nonshared environmental (E) factors (AE-model). Assuming
this AE-model, the association between the Framingham score and
regional WMHs was investigated using bivariate Cholesky de-
compositions. The bivariate genetic model tests whether the
covariance between Framingham score and WMHs could be
explained by overlapping additive genetic or overlapping non-
shared environmental factors. Maximum likelihood estimation was
used to obtain the genetic and nonshared environmental correla-
tion between Framingham score and WMHs. A high genetic cor-
relation between both traits would mean that genetic inﬂuences
affecting Framingham score are also likely to have an impact on the
presence of WMHs. The proportion of the correlation between
Framingham score andWMHs attributable to shared genetic factors
was computed.We assessedwhether therewere gender differences
by comparing ﬁts of models that allowed (co)variances for men and
women to vary with the ﬁts of models that constrained (co)vari-
ances to be the same.
Finally, we examined whether differences in WMH load within
monozygotic twin pairs are associated with differences in the Fra-
mingham score within twins, using the intrapair difference model
(De Moor et al., 2008; Vitaro et al., 2009). We regressed the
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ference in Framingham score. If these within-pair differences are
associated with each other, it indicates that nonshared environ-
mental factors inﬂuence the relationship between Framingham
score and WMHs, independent from overlapping genetic and
shared environmental factors (as these are identical within
monozygotic twin pairs).
3. Results
3.1. Sample characteristics
Demographic characteristics, vascular risk factors, and WMH
volumes are summarized in Table 1. The presence of WMHs was a
common ﬁnding, with all participants having some WMHs. Most
lesions were located in the frontal lobe and in periventricular re-
gions. Women had more WMHs than men. Demographic charac-
teristics, vascular risk factors, and WMH volumes stratiﬁed per
gender are presented in Supplementary Table 1. The average Fra-
mingham score was 23  15 and was higher in men than in women
(33  15 vs. 16  9, t ¼ 11, p < 0.001). The correlation of the Fra-
mingham score within twin pairs was 0.77 (p < 0.001). The within-
pair correlation for Framingham score items varied from 0.47
(systolic blood pressure) to 0.82 (HDL) (Table 1) (all p < 0.001).
3.2. Similarity of regional WMHs within monozygotic twin pairs
On visual inspection, WMH lesion distributions were highly
similar within twin pairs; for example, scans of 6 monozygotic twinTable 1
Baseline characteristics
Variable Total sample
(n ¼ 195)
MZ correlation
Pearson’s r
Age in years 70.3  7.3 -
Gender female 112 (57) -
Education in years 15.2  4.4 0.72a
MMSE 29.0  1.1 0.33b
CERAD total score 22.1  3.0 0.42a
CERAD delayed recall 7.4  1.3 0.42a
Visual MRI ratings
WMH (Fazekas) 1 (1e2) 0.76a
Global cortical atrophy 0.8  0.7 0.65a
Medial-temporal lobe atrophy 0.6  0.7 0.76a
Microbleeds present 44 (23) 0.39a
Lacunes present 8 (4) 0.04
Framingham 10-y risk score CVD 23.2  14.7 0.77a
Framingham score items
Systolic blood pressure, mmHg 143.2  19.6 0.47a
Glycated hemoglobin (HbA1c) 37.9  4.8 0.71a
Total cholesterol, mmol/L 5.5  1.2 0.62a
High-density lipoprotein, mmol/L 1.6  0.5 0.82a
Smoking 20 (10) 0.60a
Diabetes 10 (5) 0.70a
Antihypertensive medication 88 (45) 0.56a
WMH volume (in mL)
Total WMH 2132 (886e6692) 0.76a
Total periventricular WMH 1385 (478e4160) 0.76a
Total deep WMH 600 (204e2375) 0.72a
Frontal WMH 1301 (467e3895) 0.80a
Parietal WMH 263 (56e1079) 0.68a
Temporal WMH 161 (39e492) 0.60a
Occipital WMH 347 (124e688) 0.53a
Basal ganglia WMH 20 (7e59) 0.51a
Data are presented as mean  SD, median (IQR), or n (%).
Key: CERAD, Consortium to Establish a Registry for Alzheimer’s Disease 10-word list;
CVD, cardiovascular disease; IQR, interquartile range; MMSE, MinieMental State
Examination; MZ, monozygotic twin pair; SD, standard deviation; WMH, white
matter hyperintensity.
ap < 0.001; bp < 0.01.pairs with corresponding bullseye plots are presented in Fig. 2. The
monozygotic twin correlation for total WMH volumewas 0.76, total
periventricular WMH was 0.76, and total deep WMH was 0.72.
Regional correlations were signiﬁcant for all regions (Fig. 3A).When
examining per anatomical lobe, the average of the correlations was
highest for the frontal lobe (average r ¼ 0.71, range 0.63e0.77
across layers and hemispheres) and lowest for the occipital lobe
(average r¼ 0.42, range 0.35e0.54). Regional correlations of WMHs
in random pairs did not yield any signiﬁcant correlations. The
regional correlations were slightly higher in women than in men
(Supplementary Fig. 1).
Next, we examined whether twins had a more similar pattern of
WMH distribution across regions than random participants. Cor-
relations of WMHs across regions were higher for true twin pairs
(mean r ¼ 0.4, SD ¼ 0.25) than in random pairs (mean r ¼ 0.007,
SD ¼ 0.26) (p < 0.001) (Fig. 3B). Stratifying according to gender
yielded similar results (Supplementary Fig. 2).
3.3. Association between vascular risk factors and WMHs
Using GEEs, Framingham score was associated with total WMH
load (Table 2). Analyses according to WMH subtype and brain re-
gion showed that the Framingham score was associated with per-
iventricular WMHs in the frontal and parietal lobe. There was no
signiﬁcant relation between Framingham score and deep WMHs.
After controlling for age and gender, results remained the same
(Table 2).
We performed post hoc analysis on the individual risk items
with the Framingham score and whole-brain WMH measures to
assess whether the effects were driven by particular risk factors
(Supplementary Table 2). Systolic blood pressure and smoking
were both associated with whole-brain total WMHs (b ¼ 0.06
and b¼ 0.07 respectively, both p< 0.05) and periventricularWMHs
(b ¼ 0.06 and b ¼ 0.08 respectively, both p < 0.05). Use of antihy-
pertensive medication was associated with periventricular WMHs
(b ¼ 0.06, p < 0.05). Given the relation of age with WMHs, we also
repeated analysis calculating the Framingham score without age,
and ﬁndings remained similar (Supplementary Table 3).
3.4. Role of shared genetics and nonshared environmental factors
on the relation between vascular risk factors and WMHs
Using structural equation modeling, we determined the within-
participant and cross-twin cross-trait correlation between Fra-
mingham score and WMHs in the whole sample (Table 3) and
stratiﬁed by gender (Supplementary Table 4). We could constrain
the gender (co)variances to be the same without a signiﬁcant
decrease in model ﬁt. The cross-twin cross-trait correlation in the
genetically identical twin pairs was only 19% lower than thewithin-
participant cross-trait correlation (data for total WMHs). Assuming
an AE-model, estimates of the genetic correlation between Fra-
mingham score and WMH were obtained (Table 3). There was a
signiﬁcant genetic correlation between Framingham score and
WMHs for all regions in the whole sample. The proportion of the
correlation between Framingham score and total WMHs that could
be explained by shared genetic inﬂuences was 83%. Stratiﬁed
analysis by gender showed that the within-twin and cross-twin
cross-trait correlations as well as the genetic correlations were
signiﬁcant in all regions in women (Supplementary Table 4). In
men, the genetic correlations between both traits were lower and
signiﬁcant for 1 region (total parietal), and the nonshared envi-
ronmental correlations were signiﬁcant for periventricular and
frontal WMHs.
Finally, we assessed whether the relation between Framingham
score and WMHs is inﬂuenced by nonshared environmental factors
Fig. 2. Examples of WMH lesion distribution in 6 monozygotic twin pairs on FLAIR and in bullseye plots. Scale represents lesion load for each region. Abbreviations: FLAIR, ﬂuid-
attenuated inversion recovery; WMH, white matter hyperintensity.
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model. Regression of the intrapair differences in WMHs on the
intrapair difference in the Framingham score was signiﬁcant for
whole-brain total and periventricular WMHs (Fig. 4) and for total
and periventricular WMHs in frontal and parietal regions
(Supplementary Fig. 3) but explained little variance (r2 ¼
0.04e0.09). In males and females separately, correlations were not
signiﬁcant for most regions, although for both genders similar
trends could be observed as in the whole sample (Supplementary
Figs. 4 and 5).
As post hoc analysis, we also estimated cross-twin correlations
and twin difference analysis for systolic blood pressurewith whole-
brain total and periventricular WMHs. The within-twin cross-trait
correlation between systolic blood pressure and WMHs was 0.21
(95% conﬁdence interval [CI] ¼ 0.05e0.36) for total WMHs and 0.18
(95% CI ¼ 0.02e0.33) for periventricular WMHs. The cross-twin
cross-trait correlations were only slightly lower but not signiﬁ-
cant for both measures (0.16, 95% CI ¼ 0.00 to e0.32 for total
WMHs and 0.13, 95% CI ¼ 0.03 to e0.28 for periventricular
WMHs). Regression of the intrapair differences between systolic
blood pressure and whole-brain WMH measures were not signiﬁ-
cant (r2 ¼ 0.008 for total WMHs and r2 ¼ 0.01 for periventricular
WMHs, both p > 0.05).
4. Discussion
We found a high withinemonozygotic twin pair correlation for
total and regional WMH load and for vascular risk factors. Our re-
sults suggest a strong genetic background for the presence and
regional distribution of WMH lesions and for vascular risk factors.
Vascular risk factors were associated with WMHs, and the cross-
twin cross-trait and bivariate analyses suggested that this relation
was mainly driven by overlapping genetic inﬂuences.
Beforewe discuss these ﬁndings inmore detail, it is important to
note that we only included monozygotic twins, which precluded
ascertainment of the relative contribution of genetic and shared
environment to the monozygotic twin correlation of WMHs and
vascular risk factors. Because previous studies using a full twin
designwith both monozygotic and dizygotic twins did not ﬁnd that
shared environmental factors contribute to the withinetwin paircorrelation in WMHs and various vascular risk factors, it is likely
that our withinetwin pair correlation is driven by genetic factors
(Carmelli et al., 1998; Elder et al., 2009; Evans et al., 2003;
Fennema-Notestine et al., 2016; Kupper et al., 2005; Panizzon
et al., 2015; Poulsen et al., 1999; Rahman et al., 2009; Sachdev et al.,
2016). This implies that in our monozygotic twin study, within-twin
similarities inWMHs and vascular risk factors aremost likely due to
genetic effects.
Our ﬁndings on the genetic background of WMHs are in line
with previous studies that have estimated the heritability of total
WMHs around 0.55e0.81 (Atwood et al., 2004; Carmelli et al., 1998;
Fennema-Notestine et al., 2016; Kochunov et al., 2009; Sachdev
et al., 2016; Turner et al., 2004). We have extended on these pre-
vious studies by demonstrating that not only total and regional
WMH load are under strong genetic inﬂuence but also the pattern of
WMH distribution across the brain. Our ﬁnding of a strong genetic
component for vascular risk factors is also in line with previous
heritability studies, which found a moderate-strong genetic inﬂu-
ence on various vascular risk factors (Goode et al., 2007; Kupper
et al., 2005; Poulsen et al., 1999; Vink et al., 2005).
As expected, we found an association between vascular risk
factors and total and periventricular WMH load. We now demon-
strate that the majority (up to 83%) of the correlation between
Framingham score and total WMHs could be explained by shared
genetic inﬂuences, suggesting a strong common genetic vulnera-
bility for increased vascular risk factors and the presence of WMHs.
In line with this, the cross-twin correlation between Framingham
score and WMHs was only slightly lower than the within-
participant correlation. This indicates that in genetically identical
twins, the prediction of WMHs from a cotwin is almost as good as
from one’s own risk score. Our results are in linewith a recent study
in older adult male twin pairs that found a correlation of 0.18 be-
tween systolic blood pressure and total abnormal white matter
measured on T1, T2, and proton-density MR sequences, which could
be attributed for 86% to shared genetic inﬂuences (Fennema-
Notestine et al., 2016). A bivariate linkage analyses in a family
cohort identiﬁed various genetic loci that contribute to both blood
pressure andWMHs (Kochunov et al., 2010). A recent genome-wide
association study identiﬁed several genes associated withWMHs of
which some loci have also been associated with blood pressure
Fig. 3. Similarity of WMHs within monozygotic twin pairs. (A) Withinetwin pair
correlations in WMH for each region. Color bar represents the strength of the corre-
lation (Pearson’s r). (B) Similarity in WMH distribution pattern. Displayed are histo-
grams of WMH correlation across regions in true twin pairs and in random pairs. The
WMH data were centered per region before computing the within-pair correlation
across regions. Abbreviation: BG, basal ganglia and thalamus; FRONT, frontal; OCC,
occipital; PAR, parietal; TEMP, temporal; WMH, white matter hyperintensity. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to
the Web version of this article.)
Table 2
Relation between Framingham score and WMH lesion load
Regional WMH Model 1 Model 2
b (95% C.I.) p-
value
b (95% C.I.) p-
value
Whole-brain total 0.31 (0.08 to 0.54) 0.008 0.33 (0.05 to 0.60) 0.02
Whole-brain
periventricular
0.35 (0.10 to 0.59) 0.005 0.45 (0.18 to 0.73) 0.001
Whole-brain
deep
0.14 (0.15 to 0.44) 0.3 0.12 (0.24 to 0.48) 0.5
Frontal total 0.34 (0.12 to 0.55) 0.002 0.37 (0.09 to 0.65) 0.01
Frontal
periventricular
0.38 (0.14 to 0.62) 0.002 0.47 (0.15 to 0.79) 0.004
Frontal deep 0.11 (0.24 to 0.45) 0.5 0.13 (0.3 to 0.57) 0.6
Parietal total 0.53 (0.14 to 0.92) 0.007 0.61 (0.15 to 1.06) 0.009
Parietal
periventricular
0.44 (0.03 to 0.84) 0.03 0.59 (0.14 to 1.04) 0.01
Parietal deep 0.45 (0.04 to 0.93) 0.07 0.53 (0.07 to 1.14) 0.08
Temporal total 0.23 (0.08 to 0.54) 0.1 0.18 (0.21 to 0.58) 0.4
Temporal
periventricular
0.27 (0.11 to 0.65) 0.2 0.45 (0.02 to 0.88) 0.04
Temporal deep 0.03 (0.40 to 0.34) 0.9 0.07 (0.51 to 0.38) 0.77
Occipital total 0.24 (0.04 to 0.51) 0.09 0.36 (0.04 to 0.76) 0.08
Occipital
periventricular
0.18 (0.05 to 0.45) 0.2 0.28 (0.10 to 0.66) 0.1
Occipital deep 0.27 (0.03 to 0.58) 0.08 0.38 (0.08 to 0.84) 0.1
Basal ganglia and
thalamus
0.10 (0.25 to 0.46) 0.6 0.13 (0.29 to 0.56) 0.5
Model 1 is corrected for twin status. Model 2 is additionally corrected for age and
gender.
Key: CI, conﬁdence interval.
M. ten Kate et al. / Neurobiology of Aging 66 (2018) 40e48 45(Verhaaren et al., 2015). Several mechanisms can be postulated
through which vascular risk factors and WMHs are both the results
of other factors. For example, increased blood pressure and WMHs
could both be the result of systemic vascular stiffening, which is
also under considerable genetic inﬂuence (Aribisala et al., 2014;
Mitchell et al., 2005).
We also found that withinetwin pair differences in total and
periventricular WMHs were associated with withinetwin pair dif-
ferences in the Framingham score, although the association was
low. In other words, the twin who has a higher Framingham score
also hasmoreWMHs. This means that association between vascular
risk factors and WMHs cannot solely be explained by common
predisposing genetic (or shared environmental) factors. This in-
dicates that also nonshared environmental factors contribute to the
association between Framingham risk score and WMHs. The smalltwin difference associations are consistent with the high genetic
contribution observed in the cross-twin cross-trait analysis.
The overall association between Framingham risk score and
WMHswas relatively lowwith a correlation of around 0.3. This is in
agreement with previous studies, which also found a modest as-
sociation between vascular risk factors and WMHs (Dickie et al.,
2016; Fennema-Notestine et al., 2016; Habes et al., 2016). These
results indicate that genetic and environmental factors separate
from those associated with vascular risk factors inﬂuence WMHs.
We did not ﬁnd an association between the Framingham score and
deep WMHs. Different etiological mechanisms for deep and peri-
ventricular WMH lesions have been suggested by postmortem
studies, which revealed different pathological changes in deep and
periventricular WMHs (Gouw et al., 2011). Periventricular regions
are vascularized by distal branches from subependymal arteries,
making these regions susceptible to ischemic damage related to
reductions in cerebral blood ﬂow (Pantoni and Garcia, 1997). Large
vessel atherosclerosis may be the substrate for this cerebral hypo-
perfusion. This could explain why the Framingham score, designed
to capture the 10-year risk of cardiovascular events, which are
mainly large-vessel based, was related to periventricular but not
deep WMHs. It has been suggested that deep white matter regions
are more vulnerable to small vessel disease, for which hypertension
is an important risk factor (Kim et al., 2008). However, when
analyzing the individual risk factors, we did not ﬁnd an association
between systolic blood pressure and antihypertensive medication
use with deep WMHs either. Possibly, other factors than small
vessel disease contribute to the occurrence of deep WMHs, such as
Wallerian degeneration (McAleese et al., 2017).
Although all regions showed signiﬁcant moderate-to-high
monozygotic twin correlations in WMHs, we did see some
regional differences, with highest monozygotic twin correlations in
the frontal lobe and the lowest in the occipital lobe. This may
indicate that the contribution of genetic and environmental factors
differs across lobes. However, a previous twin study found opposite
regional differences with highest monozygotic twin correlation of
Table 3
Twin correlations between Framingham score and WMH lesion load
WMH measure Within-participant
cross-trait correlation (rp)
Cross-twin
cross-trait correlation
Genetic
correlation
Proportion rp explained
by overlapping genetic
factors (%)
Nonshared
environmental
correlation
Proportion rp explained by
overlapping nonshared
environmental factors (%)
Whole-brain total 0.32 (0.16e0.47) 0.26 (0.10e0.42) 0.36 (0.14e0.56) 83 0.23 (0.03e0.41) 17
Whole-brain perivent 0.29 (0.12e0.44) 0.20 (0.04e0.36) 0.29 (0.06e0.49) 71 0.31 (0.11e0.48) 29
Frontal total 0.29 (0.13e0.44) 0.23 (0.06e0.39) 0.32 (0.09e0.51) 79 0.27 (0.07e0.44) 21
Frontal perivent 0.28 (0.11e0.43) 0.19 (0.02e0.35) 0.26 (0.03e0.47) 68 0.32 (0.12e0.49) 32
Parietal total 0.35 (0.19e0.49) 0.27 (0.11e0.42) 0.39 (0.05e0.43) 79 0.25 (0.05e0.43) 21
Parietal perivent 0.30 (0.14e0.44) 0.22 (0.06e0.37) 0.33 (0.09e0.54) 74 0.24 (0.04e0.42) 26
Data are displayed as correlation coefﬁcient (95% conﬁdence interval) or percentage. We only computed bivariate correlations in those regions for which we found a signiﬁcant
association between Framingham score and WMHs in the GEE analysis (Table 2). Estimates of the genetic and nonshared environmental correlation are based on bivariate
genetic modeling, assuming an AE-model.
Key: GEE, generalized estimating equation; perivent., periventricular; rp, phenotypic correlation between Framingham score and WMH load; WMH, white matter
hyperintensity.
Fig. 4. Withinetwin pair difference model. Within-pair differences in vascular risk
factors were regressed on the within-pair differences in total WMHs (A) and peri-
ventricular WMHs (B). In monozygotic twin pairs, this analysis allows assessment of
the relation between vascular risk factors and WMHs, while factoring out the inﬂuence
of genetic factors. Abbreviation: WMH, white matter hyperintensity.
M. ten Kate et al. / Neurobiology of Aging 66 (2018) 40e4846WMHs in the occipital lobe (Sachdev et al., 2016). Possible differ-
ences between studies could be due to differences in populations,
although average age and gender distribution was similar, or
technique to measure and regionally classify WMHs. More research
is needed to elucidate these regional differences. We also saw
regional differences in the association between Framingham score
and WMHs, with a signiﬁcant association for the frontal and pari-
etal lobes, a trend for the occipital lobe but no association for the
temporal lobe. Although this may imply that vascular risk factors
affect anatomical lobes differently, it is also possible that we did not
ﬁnd an effect for the temporal lobe due to the overall low WMH
load in this region.
A common genetic vulnerability for the presence of WMHs and
increased vascular risk factors does not imply that management of
cardiovascular risk factors is not beneﬁcial against WMH progres-
sion or prevention of future cognitive decline. Vascular risk factors
are modiﬁable, and their presence might additionally aggravate
existing WMHs in those with a (genetic) predisposition. However,
so far, few randomized controlled trials have targeted prevention of
WMHs by reducing vascular risk factors, and these had minimal
effect (Bath and Wardlaw, 2015).
In agreement with previous studies, we found a higher WMH
load in women than in men (Wen and Sachdev, 2004; de Leeuw
et al., 2001), although women had lower Framingham scores (and
lower systolic blood pressure and less often used antihypertensive
medication). In addition, we found stronger within-participant and
cross-twin correlations between Framingham score and WMHs in
women than in men. This could be a power issue, as the effect sizes
were within a similar range for both genders, but we had less male
twin pairs (n ¼ 40) compared to female pairs (n ¼ 55). Another
possibility is that women have a higher vulnerability of vascular
risk factors on WMHs than men. Differences between men and
women have also been found for cardiovascular disease elsewhere
in the body (including coronary heart disease), with different risks
and different outcomes (Regitz-Zagrosek, 2006). This might suggest
different mechanisms to be involved. Possibly, genes located on sex
chromosomes, biological differences between sexes (e.g., hor-
mones), or mitochondrial inheritance might explain these differ-
ences between men and women. Another explanation might be
that there is a difference in cardiovascular disease management
between men and women, where women are more often under-
treated (Bugiardini et al., 2011).
Our study has several limitations. Classic twin studies include
both monozygotic and dizygotic twins in their analysis. Because we
only included monozygotic twin pairs in the present study, we
could not investigate a possible effect of shared environmental
factors (or dominant genetic effects) on WMHs, vascular risk fac-
tors, and their relation. To examine the relationship between
M. ten Kate et al. / Neurobiology of Aging 66 (2018) 40e48 47regional WMHs and vascular risk factors, we have used the com-
posite Framingham risk score, which includes various vascular
phenotypes. We opted to use this composite score in the primary
analysis to reduce the total number of statistical tests. A limitation
of this method is that different vascular risk factors are combined,
which each may have a different genetic correlation with WMHs.
Previous studies have found shared genetic inﬂuences for some, but
not all, of the vascular risk factors included in the Framingham
score in older adults (Hong et al., 1997; Panizzon et al., 2015),
consistent with our post hoc ﬁndings that mainly blood pressure
was associated with WMHs. Another limitation of our study is the
cross-sectional design. Longitudinal studies in monozygotic twins
may givemore insight into the causal relation between vascular risk
factors and the presence of WMHs and their rate of progression
over time. Furthermore, there may be a selection bias in the studied
sample. Although, in general, ascertainment by twinning allows
obtaining a random population-based sample representative of the
general population, we did have a relatively healthy and highly
educated sample due to our inclusion criterion of both twins
needing to be cognitively normal and willing to participate in the
study. Because we are examining a cognitively normal sample, the
overallWMH loadwas relatively lowand this limited the analysis in
temporal and occipital regions. Future studies that aim to elucidate
the relation between vascular risk andWMHsmay beneﬁt from also
including participants with more severe WMH lesions that might
have led to (mild) cognitive impairment. In addition, this study had
a smaller sample of men than women, which may have inﬂuenced
the results. Replication of these ﬁndings in larger samples in war-
ranted. Finally, results are dependent on the quality of the auto-
mated WMH segmentation. Although all segmentations passed
visual quality control, it must be noted that the detection of lesions
is more challenging when very close to the cortex.
In conclusion, we found that WMH load and regional distribu-
tion is highly similar in monozygotic twins, suggesting a strong
genetic inﬂuence on the occurrence and distribution of WMHs.
Periventricular, but not deep, WMHs are associated with the Fra-
mingham score. Furthermore, our results suggest a shared genetic
vulnerability between the presence of vascular risk factors and
increased total and periventricular WMHs.
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